Laurion Capital Management LP Amgen Inc Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.2 Million - $2.68 Million	8,387 New	8,387 $2.62 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $3.22 Million - $3.64 Million	12,611 New	12,611 $3.63 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $2.13 Million - $2.37 Million	9,221 New	9,221 $2.24 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $279,984 - $328,035	-1,319 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $369,757 - $410,218	-1,583 Reduced 54.55%	1,319 $322,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $4.09 Million - $4.61 Million	-22,092 Reduced 88.39%	2,902 $602,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $2.22 Million - $2.5 Million	13,394 Added 115.47%	24,994 $4.61 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $491,347 - $574,200	-2,900 Reduced 20.0%	11,600 $1.98 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $2.43 Million - $2.77 Million	14,500	14,500 $2.7 Million

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.